One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Wound Debridement Market

[ 英語タイトル ] Wound Debridement Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0084259
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 111
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Arobella Medical
- B. Braun Melsungen AG
- DeRoyal Industries
- Histologics, LLC
- Lohmann & Rauscher
- Medaxis LLC
- Misonix, Inc.
- Monarch Labs
- PulseCare Medical
- Smith & Nephew plc

[Report Description]

Factors such as rising incidence of diabetes & associated wounds, an increase in the volume of surgical procedures and growing geriatric population are driving the growth of the wound debridement market. The incidence of diabetes among all ages is increasing, mainly due to obesity, unhealthy diet, and physical inactivity. The incidence of chronic wounds, especially foot ulcers is increasing among the diabetic population resulting in the increased usage of wound debridement products. Therefore, the growing focus toward the development of better treatment options, along with huge burden of diseases is expected to drive the wound debridement market. However, the high treatment cost is expected to restrain the growth of the global market in the forecast period.

Key Market Trends

Gels Segment is Expected to Dominate the Market in the Forecast Years

Based on products, the market is segmented into gels, ointments & creams, surgical devices, Ultrasound devices, mechanical debridement pads, and other wound debridement products. Gels segment is expected to dominate the market as it maintains a moist wound environment and had certain benefits as compared to other products such as no inflammation, less bleeding, and removal of necrotic tissues safely, without causing infection. These are recommended for wounds that range from dry to mildly exudating as one of the important barriers to wound healing is the removal of necrotic tissue from the wound bed. In addition, increase in volume of surgical procedures and rising diabetic population also contributes to the growth of wound debridement market.

North America leads the Wound Debridement Market

North America leads the wound debridement market owing to growing geriatric and diabetic populations, followed by Europe. However, Asia Pacific is expected to grow at a faster rate due to the increasing awareness regarding advanced treatment options, rising incidence of chronic wounds and the presence of emerging economies in this region.

Competitive Landscape

The Wound Debridement market is competitive and many of the global players are into the market. For instance - Arobella Medical, B. Braun Melsungen AG, DeRoyal Industries, Histologics LLC, Lohmann & Rauscher, Medaxis AG, Misonix, Inc., Smith & Nephew plc etc. are providing these products across the globe.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Diabetes and Associated Wounds
4.2.2 Increase in Volume of Surgical Procedures
4.2.3 Growing Geriatric Population
4.3 Market Restraints
4.3.1 High Treatment Cost
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Gels
5.1.2 Ointments & Creams
5.1.3 Surgical Devices
5.1.4 Ultrasound Devices
5.1.5 Mechanical Debridement Pads
5.1.6 Other Wound Debridement Products
5.2 By Method
5.2.1 Surgical Method
5.2.2 Enzymatic Method
5.2.3 Mechanical Method
5.2.4 Autolytic Method
5.2.5 Others
5.3 By Wound Type
5.3.1 Chronic Ulcers
5.3.2 Surgical & Traumatic Wounds
5.3.3 Burns
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Arobella Medical
6.1.2 B. Braun Melsungen AG
6.1.3 DeRoyal Industries
6.1.4 Histologics, LLC
6.1.5 Lohmann & Rauscher
6.1.6 Medaxis LLC
6.1.7 Misonix, Inc.
6.1.8 Monarch Labs
6.1.9 PulseCare Medical
6.1.10 Smith & Nephew plc




Recommended reports